Par Drugs And Chemicals Limited has informed the Exchange regarding Re-Appointment of M/s DG Patel & Associates, Practicing Company Secretaries as secretarial auditor of the company w.e.f. April 01, 2025.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited held its 26th AGM on September 27, 2025, in Vadodara, with 42 shareholders present out of 14,498 total. All seven resolutions were passed with requisite majority, including adoption of FY25 audited financial statements (99.99% in favour), re-appointment of Chairman and Managing Director Mr. Falgun Vallabhbhai Savani via rotation (93.74%), re-appointment of statutory auditor M/s Sarupria Somani & Associates (99.85%), appointment of M/s DG Patel & Associates as Secretarial Auditor for a 5-year term covering FY26–FY30 (99.84%), ratification of Cost Auditor remuneration (99.85%), and re-appointment of Independent Director Mrs. Bintal Bhaveshkumar Shah for a second 5-year term ending September 27, 2030 (99.85%). Remote e-voting was open from September 23–26, 2025, and the scrutiniser Dip G. Patel of DG Patel & Associates confirmed the results.
Routine AGM housekeeping — no major governance disruption. Continuity is maintained with the CMD, statutory auditor, and an Independent Director all re-appointed, while a new long-term secretarial auditor has been engaged. Shareholders should note no material financial or strategic changes were announced.